MoneyMarkets Rubius Therapeutics started at overweight with $28 stock price target at J.P. Morgan By Market Watch - August 13, 2018 0 243 Share Facebook Twitter Google+ Pinterest WhatsApp This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. Source : MTV